AB BioTechnologies has unveiled plans to invest $10.5 million to construct and equip a new 23,000 square foot manufacturing facility in Bloomington, IN, and create up to 33 jobs by 2020. The company will add manufacturing services for formulating, filling, freeze-drying, and packaging injectable drugs for clinical trial studies.

“This is a fantastic opportunity for AB BioTechnologies, Bloomington, Monroe County, and the state of Indiana,” said Jeff Schwegman, founder and chief executive officer, AB BioTechnologies. “We are one of only a handful of companies in the world that will offer all of these services in a small, nimble company format, and Monroe County is the perfect place for us to expand. The presence of a locally skilled workforce and access to graduates from Indiana University and Ivy Tech will assist us in hiring a competent workforce.”

AB BioTechnologies was founded in 2008 and has expanded into an internationally-recognized drug development company in the pharmaceutical industry. With the addition of its contract manufacturing services, the company will be able to shorten the time it takes to transfer a drug from concept to the clinic.

Visit AB BioTechnologies at Interphex Booth 1539.